Manning & Napier Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $22.6M | Sell |
|
|||||
|
2023
Q4 | $27.1M | Sell |
|
|||||
|
2023
Q3 | $29.4M | Sell |
|
|||||
|
2023
Q2 | $30.6M | Buy |
|
|||||
|
2023
Q1 | $31M | Sell |
|
|||||
|
2022
Q4 | $32.2M | Sell |
|
|||||
|
2022
Q3 | $23.4M | Sell |
|
|||||
|
2022
Q2 | $23.7M | Sell |
|
|||||
|
2022
Q1 | $25.3M | Sell |
|
|||||
|
2021
Q4 | $33M | Sell |
|
|||||
|
2021
Q3 | $33.4M | Sell |
|
|||||
|
2021
Q2 | $33.5M | Buy |
|
|||||
|
2021
Q1 | $27.1M | Buy |
|
|||||
|
2020
Q4 | $23.8M | Sell |
|
|||||
|
2020
Q3 | $27.7M | Sell |
|
|||||
|
2020
Q2 | $34M | Buy |
|
|||||
|
2020
Q1 | $31M | Sell |
|
|||||
|
2019
Q4 | $29.4M | Buy |
|
|||||
|
2019
Q3 | $25.8M | Buy |
|
|||||
|
2019
Q2 | $27.3M | Buy |
|
|||||
|
2019
Q1 | $22.2M | Buy |
|
|||||
|
2018
Q4 | $17.1M | Buy |
|
|||||
|
2018
Q3 | $19.2M | Buy |
|
|||||
|
2018
Q2 | $16.5M | Buy |
|
|||||
|
2018
Q1 | $16.1M | Buy |
|
|||||
|
2017
Q4 | $12.4M | Buy |
|